Top Markets
Coin of the day
Filana Therapeutics, Inc. Filana Therapeutics, Inc.

Filana Therapeutics, Inc.

FLNA
Rank in Stocks #25914
Filana Therapeutics, Inc. is a company dedicated to pioneering new... Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
Share Price
$0.9342
Market Cap
$45.13M
Change (1 day)
-3.31%
Change (1 year)
-
Country
US
Trade Filana Therapeutics, Inc. (FLNA)

Category

Operating Margin for Filana Therapeutics, Inc. (FLNA)
Operating Margin as of 2026 TTM: 0.00%
According to Filana Therapeutics, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Filana Therapeutics, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
25.72% -
AU
0.00% -
CH
-149.01% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.